NBIS:NASDAQNebius Group N.V. Analysis
Data as of 2026-05-19 - not real-time
$183.96
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nebius Group N.V. (NBIS) is trading well above its short‑ and medium‑term moving averages (SMA‑20 = 174.07, SMA‑50 = 144.60, SMA‑200 = 107.24) and the price sits comfortably above the key support of $132.70, suggesting a sustained bullish bias. Technicals reinforce this view: the MACD line is above its signal (bullish), the RSI at 54.7 indicates neither overbought nor oversold conditions, and volume is on an increasing trend. The stock’s volatility is extreme (30‑day ≈ 102%) and beta is high (~3), flagging significant price swings and market‑related risk. Fundamentals paint a mixed picture: a trailing PE of 70.8 versus an industry average of 17.2 signals apparent overvaluation, yet the DCF‑derived fair value of $276.90 implies roughly 25% upside from the current $183.96 price. Recent news highlights a spectacular 684% revenue surge driven by AI services, a strategic NVIDIA alliance, and a new gigawatt‑scale AI factory, all underpinning strong growth momentum. However, the balance sheet is strained with a debt‑to‑equity of 131 and negative free cash flow, raising financing concerns.
Overall, NBIS offers compelling growth catalysts and bullish technical signals, but investors must weigh the high valuation multiples, elevated volatility, and leverage. The current market sentiment is extremely greedy (Fear‑Greed Index = 89.2), which may inflate price expectations in the short run, while the long‑term outlook hinges on the company’s ability to convert rapid revenue expansion into sustainable profitability and debt reduction.
Overall, NBIS offers compelling growth catalysts and bullish technical signals, but investors must weigh the high valuation multiples, elevated volatility, and leverage. The current market sentiment is extremely greedy (Fear‑Greed Index = 89.2), which may inflate price expectations in the short run, while the long‑term outlook hinges on the company’s ability to convert rapid revenue expansion into sustainable profitability and debt reduction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMA‑20/50/200, MACD bullish)
- Increasing volume supporting momentum
- Recent earnings beat and revenue surge
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong AI infrastructure demand and NVIDIA partnership
- DCF upside of ~25% and supportive DCF fair value
- Continued capex expansion (new AI factory) driving growth
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and negative free cash flow require debt reduction
- Valuation may compress if earnings do not keep pace with PE multiples
- Long‑term AI market tailwinds provide sustainable growth potential
Key Metrics & Analysis
Financial Health
Revenue Growth621.50%
Profit Margin93.09%
P/E Ratio70.8
ROE14.14%
ROA-3.01%
Debt/Equity131.13
P/B Ratio6.5
Op. Cash Flow$2.8B
Free Cash Flow$-6128775168
Industry P/E17.2
Technical Analysis
TrendBullish
RSI54.7
Support$132.70
Resistance$233.73
MA 20$174.07
MA 50$144.60
MA 200$107.24
MACDBullish
VolumeIncreasing
Fear & Greed Index89.2
Valuation
Fair Value$276.90
Target Price$230.77
Upside/Downside25.45%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta2.97
Volatility102.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.